Navigation Links
SkilaMederi and Qforma Announce Merger
Date:6/6/2013

MORRIS PLAINS, N.J. and SANTA FE, N.M., June 6, 2013 /PRNewswire/ -- SkilaMederi, a global life-sciences social analytics strategic solutions and launch optimization provider, and Qforma, a leading provider of advanced analytics and predictive technologies for the life sciences industry, announce their merger. BelHealth Investment Partners, a healthcare private equity firm and majority owner of SkilaMederi, will support the merger with an additional equity investment.

(Logo: http://photos.prnewswire.com/prnh/20130606/NY25906LOGO )

SkilaMederi, in business since 1995, is a leading provider of global product launch optimization and stakeholder engagement insight that drive measurable value for life sciences companies. SkilaMederi's CrowdLink™ stakeholder analytics platform and iLaunch™ intelligent launch optimization services are used around the globe by industry-leading medical, marketing, market access and sales teams at pharmaceutical, biotechnology and medical device companies.

Qforma, formed in 2000 from technology initially developed at Los Alamos National Laboratory, empowers its healthcare customers with actionable insights, quantified metrics, and timely alerts to impending change. Qforma has established itself as the leader in Community Opinion Leader mapping, which is critical as healthcare companies continue to educate physicians about new therapies in a resource-challenged environment.

NewCo will be called Qforma and will emerge as a leading provider of healthcare data analytics. It will focus on social analytics, stakeholder engagement insights, predictive modeling and launch optimization. As the health care industry evolves, decision makers increasingly rely on real-time actionable intelligence. The combined company is uniquely positioned to provide insights from thousands of local experts in any given disease or condition, Accountable Care Organizations (ACO), Managed Care Organizations, healthcare provider groups, integrated health systems and hospitals.

The key strategic benefits of the merger include:

  • Comprehensive product offering: The combined company will have the most unique and broad product offering that will help pharmaceutical, biotechnology and medical device companies target their marketing efforts on a global, national and local level.
  • Leader in social network analytics: Social network data and analysis is transforming marketing tactics and NewCo is well-positioned to capitalize on this growing trend.
  • Cross marketing opportunities: The two companies have a diverse customer base without much overlap. This provides immediate cross-selling opportunities.
  • Global presence: Qforma will have six offices including four in the US and two in Europe enabling the company to effectively and efficiently service its customers.

Kilian Weiss , Chief Executive Officer of SkilaMederi, will lead the combined organization. "The merger allows us to create a unique combination of social analytics with real world healthcare data and provide the life sciences industry with unparalleled, actionable intelligence. I am very impressed with the capabilities of the Qforma software team. Santa Fe is well-known for complex research and development and the combined company can benefit from this pool of technical expertise."

Roger D. Jones , PhD, Co-Founder of Qforma and director of NewCo said, "The merger allows us to bring non-traditional data sets such as social media into our analysis. We have been looking to add social media data to our capability for some time, and to merge with SkilaMederi, the leader in this area, provides our customers a tremendous opportunity. We could not have chosen a better partner in terms of innovation and commitment to customers. We will utilize SkilaMederi's global presence to bring exciting products to new clients worldwide." Roger added, "Working with Kilian and BelHealth has been a pleasure."

"BelHealth's strategy is to create a leading provider in the fragmented pharmaceutical analytics market and the merger brings us closer to our goal. We have evaluated several acquisition prospects for SkilaMederi over the past year and Qforma is clearly the perfect fit. We are very excited about NewCo's positioning and opportunity" said, Inder Tallur , Managing Director of BelHealth Investment Partners, L.P. "The combination of traditional pharmaceutical data analytics, combined with social media sentiment and network analysis, is a major step forward for the healthcare industry, and we are proud to lead the way."

NewCo will have a global presence with facilities in Frankfurt, Germany; Lviv, Ukraine; Santa Fe, New Mexico; Princeton, New Jersey; Chicago, Illinois and headquarters in Morris Plains, New Jersey.

About BelHealth Investment Partners
BelHealth Investment Partners, based in New York, is a healthcare private equity firm focused on lower middle market companies. BelHealth acquires majority positions in entrepreneur-owned companies we believe would benefit from our vast operating and private equity experience. The firm typically invests $10-25 million per platform company across three healthcare segments: Services, Information Technology and Products & Distribution. Applying an active, hands-on approach, BelHealth utilizes its experience to support management, drive revenue and profit growth and achieve superior returns for its investors and partners.

For further information, please visit www.belhealth.com  


'/>"/>
SOURCE SkilaMederi
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. SkilaMederi Names Ray Joske as Chief Commercial Officer
2. Qforma Chief Technologist Honored as One of PharmaVOICE Magazines "100 Most Inspiring People in the Life Sciences"
3. Qforma Appoints New VP, Business Development
4. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
5. Maroon 5 Lead Singer Adam Levine and Shire Announce "The Own It Project," Encouraging Adults with Attention-Deficit/Hyperactivity Disorder to Tell Their Stories Through a National Contest
6. Alexza to Announce 2012 First Quarter Financial Results on Thursday, May 10, 2012
7. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
8. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
9. Misonix Announces New Distribution Agreement For Panama
10. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
11. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... , Kalifornien, 12. Februar 2016  Sequent ... der Aufnahme von Patienten für eine Studie zur ... Aneurysmen („WEB") speziell für die Behandlung von rupturierten ... , MD, Leiter der Neuroradiologie an der Universitätsklinik ... und Hauptprüfarzt der CLARYS-Studie hat den ersten Patienten ...
(Date:2/12/2016)... , Feb. 12, 2016  Eli Lilly and Company ... Court decided the Alimta® (pemetrexed disodium) vitamin regimen patent would ... the UK, France , Italy ... to dilute the product only with dextrose solution.  ... 2015, the UK Court of Appeal held that Lilly,s patent ...
(Date:2/12/2016)... BUDAPEST , Ungarn, February 12, 2016 ... ein Medizintechnikunternehmen, das sich auf den ungedeckten ... gab heute positive Ergebnisse seines klinischen Forschungsprogramms ... und Asthma-Patienten beschäftigt, ergab Verbesserungen ihrer respiratorischen ... Indiso ltd , ein Medizintechnikunternehmen, das ...
Breaking Medicine Technology:
(Date:2/13/2016)... ... ... DDi , a Makro company, makes it to ... in eClinical Solutions. DDi has built its solution competency with a unique blend ... DDi provides smarter technology for Clinical Development, Regulatory and Enterprise domains by providing ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through ... over 250 members of South Florida’s philanthropic community at its 10th anniversary Fashion ...
(Date:2/12/2016)... ... 2016 , ... Coco Libre, the maker of coconut water beverages with a ... Lounge Event. Coco Libre will offer musicians and celebrities the company’s signature Organic Coconut ... invitation-only gifting suite, held this year at the W Hollywood Hotel, has become a ...
(Date:2/12/2016)... ... February 12, 2016 , ... Fisher House Foundation Chairman ... John J. Lee, Nevada Military Support Alliance president Scott Bensing, and Peggy Kearns Director, ... VA Southern Nevada Healthcare System. This will be the first Fisher House in ...
(Date:2/12/2016)... ... February 12, 2016 , ... Young ... area, celebrates the beginning of the latest charity campaign in their community enrichment ... art. Donations to this worthy cause are currently being accepted at: http://artexpressioninc.org/ ...
Breaking Medicine News(10 mins):